Last Close
Jun 22  •  04:00PM ET
36.33
Dollar change
-0.16
Percentage change
-0.45
%
Category
Global or ExUS Equities - Industry Sector
Asset Type
Equities (Stocks)
Tags
Return% 1Y
35.56%
Total Holdings
65
Perf Week
2.47%
Sponsor
Franklin Templeton
ETF Type
Tags
Return% 3Y
5.57%
AUM
23.71M
Perf Month
7.89%
Fund Family
Bond Type
Tags
Return% 5Y
-4.77%
NAV/sh
Perf Quarter
14.65%
Index
-
Average Maturity
Tags
Return% 10Y
52W High
38.17 -4.83%
Perf Half Y
0.07%
Index Weighting
Commodity Type
Tags
-
Return% SI
52W Low
26.99 34.59%
Perf YTD
0.05%
Active/Passive
Quant Type
Tags
-
Flows% 1M
0.00%
Volatility
0.33% 0.20%
Perf Year
33.21%
ESG Type
Tags
-
Flows% 3M
0.00%
ATR (14)
0.47
Perf 3Y
19.94%
Dividend Type
Sector/Theme
Flows% YTD
8.55%
RSI (14)
61.50
Perf 5Y
-23.50%
Structure Type
Region
Flows% 1Y
Beta
0.99
Perf 10Y
-
Expense
0.50%
Growth/Value
SMA20
2.99%
Flows% 3Y
Rel Volume
0.63
Prev Close
36.49
Inverse/Leveraged
Market Cap
SMA50
5.81%
Flows% 5Y
Avg Volume
0.58K
Price
36.33
IPO
Feb 27, 2020
Option/Short
Yes / No
SMA200
5.54%
Trades
Volume
376
Change
-0.45%
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.